recombinant fowlpox virus
Vaccineexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2007 (NCT00333424)
Timeline
2000s
- Jan 1, 2007
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Tumor antigensImmunity, active
immunity, active - tumor antigens
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- recombinant fowlpox virus
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00333424 | Phase 1/Phase 2 (Phase 2) | Aug 1, 2007 | HIV-NAT Thai Red Cross AIDS Research Center, Thai Red Cross AIDS Research Centre, Bangkok, Thailand, University of New South Wales |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| HIV-NAT Thai Red Cross AIDS Research Center | Academic/Hospital | 1 | 0 | 1 | 2007 |
| Thai Red Cross AIDS Research Centre, Bangkok, Thailand | Academic/Hospital | 1 | 0 | 1 | 2007 |
| University of New South Wales | Academic/Hospital | 1 | 1 | 1 | 2007 |
3 organizations
Page 1 / 1